{
  "oncology_immunotherapy": [
    {
      "patent_number": "US10000001",
      "title": "Checkpoint inhibitor combination therapy for solid tumors",
      "assignee": "OncoBio Inc.",
      "filing_date": "2014-06-15",
      "grant_date": "2018-07-10",
      "cited_by_count": 210,
      "url": "https://patents.google.com/patent/US10000001"
    },
    {
      "patent_number": "US10000002",
      "title": "PD-1 antibody formulations with improved stability",
      "assignee": "PharmaGen Corp.",
      "filing_date": "2015-03-02",
      "grant_date": "2019-01-05",
      "cited_by_count": 145,
      "url": "https://patents.google.com/patent/US10000002"
    },
    {
      "patent_number": "US10000003",
      "title": "Neoantigen-based personalized cancer vaccine",
      "assignee": "ImmuneNext Biotech",
      "filing_date": "2017-11-21",
      "grant_date": "2021-02-18",
      "cited_by_count": 95,
      "url": "https://patents.google.com/patent/US10000003"
    },
    {
      "patent_number": "US10000004",
      "title": "Bispecific antibody targeting PD-L1 and CTLA-4",
      "assignee": "OncoBio Inc.",
      "filing_date": "2016-09-09",
      "grant_date": "2020-03-30",
      "cited_by_count": 130,
      "url": "https://patents.google.com/patent/US10000004"
    },
    {
      "patent_number": "US10000005",
      "title": "Combination of immune checkpoint inhibitor with oncolytic virus",
      "assignee": "ViroThera Ltd.",
      "filing_date": "2018-01-12",
      "grant_date": "2022-06-01",
      "cited_by_count": 40,
      "url": "https://patents.google.com/patent/US10000005"
    }
  ],
  "diabetes_glp1": [
    {
      "patent_number": "US20000001",
      "title": "Long-acting GLP-1 receptor agonist formulations",
      "assignee": "MetaboRx Pharma",
      "filing_date": "2013-04-10",
      "grant_date": "2017-05-20",
      "cited_by_count": 180,
      "url": "https://patents.google.com/patent/US20000001"
    },
    {
      "patent_number": "US20000002",
      "title": "Once-weekly injectable GLP-1 analogs",
      "assignee": "Nordic Endocrine A/S",
      "filing_date": "2012-09-01",
      "grant_date": "2016-02-11",
      "cited_by_count": 220,
      "url": "https://patents.google.com/patent/US20000002"
    },
    {
      "patent_number": "US20000003",
      "title": "Oral GLP-1 delivery using permeation enhancers",
      "assignee": "OralBio Therapeutics",
      "filing_date": "2016-07-19",
      "grant_date": "2020-01-09",
      "cited_by_count": 75,
      "url": "https://patents.google.com/patent/US20000003"
    },
    {
      "patent_number": "US20000004",
      "title": "Fixed-dose combination of GLP-1 agonist with basal insulin",
      "assignee": "MetaboRx Pharma",
      "filing_date": "2015-11-05",
      "grant_date": "2019-09-14",
      "cited_by_count": 110,
      "url": "https://patents.google.com/patent/US20000004"
    },
    {
      "patent_number": "US20000005",
      "title": "Cardioprotective GLP-1 analogs for high‑risk diabetics",
      "assignee": "CardioMetrix AG",
      "filing_date": "2017-03-30",
      "grant_date": "2021-08-03",
      "cited_by_count": 60,
      "url": "https://patents.google.com/patent/US20000005"
    }
  ],
  "alzheimers_amyloid": [
    {
      "patent_number": "US30000001",
      "title": "Monoclonal antibodies targeting aggregated beta-amyloid",
      "assignee": "NeuroCure Inc.",
      "filing_date": "2010-02-13",
      "grant_date": "2014-06-25",
      "cited_by_count": 260,
      "url": "https://patents.google.com/patent/US30000001"
    },
    {
      "patent_number": "US30000002",
      "title": "Subcutaneous formulations of anti-amyloid antibodies",
      "assignee": "NeuroCure Inc.",
      "filing_date": "2012-08-09",
      "grant_date": "2016-01-19",
      "cited_by_count": 150,
      "url": "https://patents.google.com/patent/US30000002"
    },
    {
      "patent_number": "US30000003",
      "title": "Small-molecule inhibitors of amyloid aggregation",
      "assignee": "CognitiveRx Ltd.",
      "filing_date": "2015-10-03",
      "grant_date": "2019-04-27",
      "cited_by_count": 95,
      "url": "https://patents.google.com/patent/US30000003"
    },
    {
      "patent_number": "US30000004",
      "title": "Amyloid PET imaging agents with improved brain penetration",
      "assignee": "ImagingDx Corp.",
      "filing_date": "2013-01-18",
      "grant_date": "2017-09-12",
      "cited_by_count": 70,
      "url": "https://patents.google.com/patent/US30000004"
    },
    {
      "patent_number": "US30000005",
      "title": "Combination of anti-amyloid antibody with BACE inhibitor",
      "assignee": "NeuroCure Inc.",
      "filing_date": "2016-06-07",
      "grant_date": "2020-11-30",
      "cited_by_count": 55,
      "url": "https://patents.google.com/patent/US30000005"
    }
  ],
  "asthma_biologics": [
    {
      "patent_number": "US40000001",
      "title": "Anti-IL-5 antibody for severe eosinophilic asthma",
      "assignee": "RespiraBio plc",
      "filing_date": "2011-05-22",
      "grant_date": "2015-09-17",
      "cited_by_count": 190,
      "url": "https://patents.google.com/patent/US40000001"
    },
    {
      "patent_number": "US40000002",
      "title": "Anti-IL-4/IL-13 bispecific antibody compositions",
      "assignee": "AllerGenix Inc.",
      "filing_date": "2013-09-11",
      "grant_date": "2017-02-03",
      "cited_by_count": 130,
      "url": "https://patents.google.com/patent/US40000002"
    },
    {
      "patent_number": "US40000003",
      "title": "Subcutaneous depot formulations for asthma biologics",
      "assignee": "RespiraBio plc",
      "filing_date": "2015-02-04",
      "grant_date": "2019-06-09",
      "cited_by_count": 80,
      "url": "https://patents.google.com/patent/US40000003"
    },
    {
      "patent_number": "US40000004",
      "title": "Biologics for steroid‑refractory asthma",
      "assignee": "PulmoNext Therapeutics",
      "filing_date": "2016-10-14",
      "grant_date": "2020-03-14",
      "cited_by_count": 60,
      "url": "https://patents.google.com/patent/US40000004"
    },
    {
      "patent_number": "US40000005",
      "title": "Inhaled biologic delivery for type‑2 asthma",
      "assignee": "AeroBio Devices",
      "filing_date": "2017-12-19",
      "grant_date": "2021-07-01",
      "cited_by_count": 35,
      "url": "https://patents.google.com/patent/US40000005"
    }
  ],
  "antibiotic_resistance": [
    {
      "patent_number": "US50000001",
      "title": "Novel beta-lactamase inhibitors for multi‑drug resistant infections",
      "assignee": "InfectioRx Inc.",
      "filing_date": "2012-03-05",
      "grant_date": "2016-01-11",
      "cited_by_count": 160,
      "url": "https://patents.google.com/patent/US50000001"
    },
    {
      "patent_number": "US50000002",
      "title": "Combination of polymyxin with efflux pump inhibitors",
      "assignee": "ResistX Pharma",
      "filing_date": "2014-09-12",
      "grant_date": "2018-05-23",
      "cited_by_count": 90,
      "url": "https://patents.google.com/patent/US50000002"
    },
    {
      "patent_number": "US50000003",
      "title": "Rapid diagnostics for carbapenem‑resistant Enterobacteriaceae",
      "assignee": "MicroDx Solutions",
      "filing_date": "2015-06-01",
      "grant_date": "2019-02-28",
      "cited_by_count": 70,
      "url": "https://patents.google.com/patent/US50000003"
    },
    {
      "patent_number": "US50000004",
      "title": "Bacteriophage cocktails targeting resistant Gram‑negative pathogens",
      "assignee": "PhageThera Ltd.",
      "filing_date": "2016-08-17",
      "grant_date": "2020-10-06",
      "cited_by_count": 55,
      "url": "https://patents.google.com/patent/US50000004"
    },
    {
      "patent_number": "US50000005",
      "title": "Host‑directed therapies to combat antibiotic resistance",
      "assignee": "ImmunoBalance Biotech",
      "filing_date": "2017-11-08",
      "grant_date": "2021-09-20",
      "cited_by_count": 40,
      "url": "https://patents.google.com/patent/US50000005"
    }
  ]
}
